Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion type Assertion NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_head.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion description "[Activation of PPARgamma, a nuclear hormone receptor important for lipid and glucose homeostasis, may present a new therapeutic approach for breast cancer, since PPARgamma agonists promote cell cycle arrest, differentiation and apoptosis in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_provenance.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion evidence source_evidence_literature NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_provenance.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion SIO_000772 18288403 NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_provenance.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion wasDerivedFrom befree-20150227 NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_provenance.
- NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_assertion wasGeneratedBy ECO_0000203 NP230930.RAErsbS3tD5I56MX_sM2Pe-VFwhpDFsp8uGPN7BEIwDA4130_provenance.